A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.
Identifieur interne : 000511 ( PubMed/Checkpoint ); précédent : 000510; suivant : 000512A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.
Auteurs : Rachel I. Vogel [États-Unis] ; Lori G. Strayer [États-Unis] ; Rehana L. Ahmed [États-Unis] ; Anne Blaes [États-Unis] ; Deann Lazovich [États-Unis]Source :
- Journal of skin cancer [ 2090-2905 ] ; 2017.
Abstract
The goal of this study was to identify a relevant and inclusive list of quality of life issues among long-term survivors of melanoma. Individuals diagnosed with stage I-III cutaneous melanoma and had survived 1-5 years, ages 18-65 years at diagnosis, were recruited. Five focus groups were conducted with 33 participants in total. Discussions centered on participants' experiences at diagnosis, as well as ongoing physical, emotional, and social concerns, and behavioral changes since diagnosis. The majority of participants reported shock, fear, and feeling overwhelmed at the time of diagnosis. Some reported lingering physical concerns, including pain, numbness, and lymphedema, while a few reported no lasting issues. Emotional concerns were common, with most reporting anxiety. Several also noted feeling lonely and isolated. Social concerns included alteration of activities to avoid sun exposure, issues with family communication, and frustration with the lack of appreciation of the seriousness of melanoma by others. Finally, while many participants reported changes to their sun exposure and UV-protection behaviors, some reported little to no change. The shared experiences among participants in this study confirm the unique nature of melanoma and the need for interventions designed to improve the health and quality of life of melanoma survivors.
DOI: 10.1155/2017/2041872
PubMed: 28634549
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:28634549Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.</title><author><name sortKey="Vogel, Rachel I" sort="Vogel, Rachel I" uniqKey="Vogel R" first="Rachel I" last="Vogel">Rachel I. Vogel</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Strayer, Lori G" sort="Strayer, Lori G" uniqKey="Strayer L" first="Lori G" last="Strayer">Lori G. Strayer</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L" last="Ahmed">Rehana L. Ahmed</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Blaes, Anne" sort="Blaes, Anne" uniqKey="Blaes A" first="Anne" last="Blaes">Anne Blaes</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Lazovich, Deann" sort="Lazovich, Deann" uniqKey="Lazovich D" first="Deann" last="Lazovich">Deann Lazovich</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28634549</idno><idno type="pmid">28634549</idno><idno type="doi">10.1155/2017/2041872</idno><idno type="wicri:Area/PubMed/Corpus">000132</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000132</idno><idno type="wicri:Area/PubMed/Curation">000132</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000132</idno><idno type="wicri:Area/PubMed/Checkpoint">000132</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000132</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.</title><author><name sortKey="Vogel, Rachel I" sort="Vogel, Rachel I" uniqKey="Vogel R" first="Rachel I" last="Vogel">Rachel I. Vogel</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Strayer, Lori G" sort="Strayer, Lori G" uniqKey="Strayer L" first="Lori G" last="Strayer">Lori G. Strayer</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L" last="Ahmed">Rehana L. Ahmed</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Blaes, Anne" sort="Blaes, Anne" uniqKey="Blaes A" first="Anne" last="Blaes">Anne Blaes</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Lazovich, Deann" sort="Lazovich, Deann" uniqKey="Lazovich D" first="Deann" last="Lazovich">Deann Lazovich</name><affiliation wicri:level="2"><nlm:affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Masonic Cancer Center, University of Minnesota, Minneapolis, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author></analytic><series><title level="j">Journal of skin cancer</title><idno type="ISSN">2090-2905</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The goal of this study was to identify a relevant and inclusive list of quality of life issues among long-term survivors of melanoma. Individuals diagnosed with stage I-III cutaneous melanoma and had survived 1-5 years, ages 18-65 years at diagnosis, were recruited. Five focus groups were conducted with 33 participants in total. Discussions centered on participants' experiences at diagnosis, as well as ongoing physical, emotional, and social concerns, and behavioral changes since diagnosis. The majority of participants reported shock, fear, and feeling overwhelmed at the time of diagnosis. Some reported lingering physical concerns, including pain, numbness, and lymphedema, while a few reported no lasting issues. Emotional concerns were common, with most reporting anxiety. Several also noted feeling lonely and isolated. Social concerns included alteration of activities to avoid sun exposure, issues with family communication, and frustration with the lack of appreciation of the seriousness of melanoma by others. Finally, while many participants reported changes to their sun exposure and UV-protection behaviors, some reported little to no change. The shared experiences among participants in this study confirm the unique nature of melanoma and the need for interventions designed to improve the health and quality of life of melanoma survivors.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28634549</PMID><DateCreated><Year>2017</Year><Month>06</Month><Day>21</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2090-2905</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Journal of skin cancer</Title><ISOAbbreviation>J Skin Cancer</ISOAbbreviation></Journal><ArticleTitle>A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.</ArticleTitle><Pagination><MedlinePgn>2041872</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2017/2041872</ELocationID><Abstract><AbstractText>The goal of this study was to identify a relevant and inclusive list of quality of life issues among long-term survivors of melanoma. Individuals diagnosed with stage I-III cutaneous melanoma and had survived 1-5 years, ages 18-65 years at diagnosis, were recruited. Five focus groups were conducted with 33 participants in total. Discussions centered on participants' experiences at diagnosis, as well as ongoing physical, emotional, and social concerns, and behavioral changes since diagnosis. The majority of participants reported shock, fear, and feeling overwhelmed at the time of diagnosis. Some reported lingering physical concerns, including pain, numbness, and lymphedema, while a few reported no lasting issues. Emotional concerns were common, with most reporting anxiety. Several also noted feeling lonely and isolated. Social concerns included alteration of activities to avoid sun exposure, issues with family communication, and frustration with the lack of appreciation of the seriousness of melanoma by others. Finally, while many participants reported changes to their sun exposure and UV-protection behaviors, some reported little to no change. The shared experiences among participants in this study confirm the unique nature of melanoma and the need for interventions designed to improve the health and quality of life of melanoma survivors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vogel</LastName><ForeName>Rachel I</ForeName><Initials>RI</Initials><Identifier Source="ORCID">0000-0003-0149-8464</Identifier><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strayer</LastName><ForeName>Lori G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Rehana L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaes</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazovich</LastName><ForeName>DeAnn</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Skin Cancer</MedlineTA><NlmUniqueID>101546757</NlmUniqueID><ISSNLinking>2090-2913</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2199-210</RefSource><PMID Version="1">20643826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2013 Nov 20;31(33):4172-8</RefSource><PMID Version="1">24043747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Care (Engl). 2012 Mar;21(2):177-86</RefSource><PMID Version="1">21848582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):591-6</RefSource><PMID Version="1">26042651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacoeconomics. 2011 Oct;29(10):863-74</RefSource><PMID Version="1">21846158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2006 Feb 27;94(4):492-8</RefSource><PMID Version="1">16449995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol. 2009 Dec;145(12):1415-27</RefSource><PMID Version="1">20026852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2015 Mar;23(3):779-89</RefSource><PMID Version="1">25189151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cutan Med Surg. 2004 Sep-Oct;8(5):303-9</RefSource><PMID Version="1">15868284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunother. 2011 May;34(4):403-8</RefSource><PMID Version="1">21499123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2012 Dec;20(12):3287-95</RefSource><PMID Version="1">22549505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pain. 2011 Dec;152(12):2721-8</RefSource><PMID Version="1">21871733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2013 Jan;22(1):106-16</RefSource><PMID Version="1">23296633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Intern Med. 2009 Nov;24 Suppl 2:S430-5</RefSource><PMID Version="1">19838845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Melanoma Res. 2014 Jun;24(3):252-60</RefSource><PMID Version="1">24584097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2006 Apr 18;6:95</RefSource><PMID Version="1">16620390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2007 Dec;25(8):758-65</RefSource><PMID Version="1">17952742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Prev. 2010 May;19(3):216-26</RefSource><PMID Version="1">20093934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 2008 Jul;67(1):79-87</RefSource><PMID Version="1">18450347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2009 Oct;18(10):1106-15</RefSource><PMID Version="1">19142859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28</RefSource><PMID Version="1">22281605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Health Psychol. 2015 Sep;20(3):594-612</RefSource><PMID Version="1">24924918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Acad Dermatol. 2012 Jan;66(1):e9-10</RefSource><PMID Version="1">22177654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2012 Sep;21(9):962-9</RefSource><PMID Version="1">21608073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2014 Nov;22(11):2973-80</RefSource><PMID Version="1">24879390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Melanoma Res. 2013 Apr;23(2):167-74</RefSource><PMID Version="1">23358427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Plast Surg. 2007 Spring;15(1):38-40</RefSource><PMID Version="1">19554129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2014 Oct;25(10):2052-8</RefSource><PMID Version="1">25081900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1557-68</RefSource><PMID Version="1">20507845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2003 Oct;238(4):528-35; discussion 535-7</RefSource><PMID Version="1">14530724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2012 Mar;21(3):255-63</RefSource><PMID Version="1">22383267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol. 2011 Feb;147(2):177-85</RefSource><PMID Version="1">21339445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Melanoma Res. 2010 Apr;20(2):147-52</RefSource><PMID Version="1">20224304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Nurs. 2005 May-Jun;28(3):172-8</RefSource><PMID Version="1">15915059</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28634549</ArticleId><ArticleId IdType="doi">10.1155/2017/2041872</ArticleId><ArticleId IdType="pmc">PMC5467303</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Minnesota</li></region></list><tree><country name="États-Unis"><region name="Minnesota"><name sortKey="Vogel, Rachel I" sort="Vogel, Rachel I" uniqKey="Vogel R" first="Rachel I" last="Vogel">Rachel I. Vogel</name></region><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L" last="Ahmed">Rehana L. Ahmed</name><name sortKey="Blaes, Anne" sort="Blaes, Anne" uniqKey="Blaes A" first="Anne" last="Blaes">Anne Blaes</name><name sortKey="Lazovich, Deann" sort="Lazovich, Deann" uniqKey="Lazovich D" first="Deann" last="Lazovich">Deann Lazovich</name><name sortKey="Strayer, Lori G" sort="Strayer, Lori G" uniqKey="Strayer L" first="Lori G" last="Strayer">Lori G. Strayer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000511 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000511 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:28634549
|texte= A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:28634549" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |